The primary composite endpoint was the time from randomization to first occurrence of a major adverse cardiovascular event (MACE): cardiovascular death, non-fatal myocardial infarction or non-fatal stroke
As a GLP-1 receptor agonist, semaglutide is typically well-tolerated and offers a reliable option to help patients reduce appetite, lower calorie intake, and achieve gradual, sustainable weight loss
doi: 10.1002/jemt.10311, 237
Some people may notice blood pressure changes earlier, especially if they lose weight, reduce sodium intake, improve sleep, increase activity, or drink less alcohol
Studies looking into hCGs effects have found that giving smaller frequent doses helps keep hormone levels steadier than larger, occasional ones